Anticholinergic load in patients older 65 years with ambulatory pharmacological treatment in a Colombian population

• Published in: Iatreia (Medellín, Colombia) Vol. 32; no. 1; pp. 25 - 32
• Main Authors: Vallejos Narváez, Álvaro Guillermo, Bello Benavides, Alejandra, Caro Uribe, Patricia, Hernández Díaz, William
• Format: Journal Article
• Language: Spanish
• Published: Universidad de Antioquia 01.01.2019
• Subjects: Anticholinergic Syndrome; Elderly; Outpatients; Polypharmacy
• ISSN: 0121-0793; 2011-7965
• DOI: 10.17533/udea.iatreia.v32n1a03

Background: Drugs with potential anticholinergic effect are usually prescribed to the population over 65 years. There are several scales created to calculate anticholinergic burden: Anticholinergic Drug Scale, Anticholinergic Risk Scale, and Anticholinergic Cognitive Burden. Objective: To characterize the anticholinergic burden in patients older than 65 years with polypharmacy who are prescribed in ambulatory settings. Methods: Retrospective cross-sectional study with information registered from April to September 2016. The database of prescription records of a health management organization (HMO), with national registries in the Pharmacy Benefit Management (PBM) technology platform, was used. Medicines were analyzed by its anticholinergic properties and anticholinergic burden. Results: There were 115,713 patients with a median age of 74 years. The medicines with moderate anticholinergic burden were dimenhydrinate, amantadine, biperidene and quetiapine in 6.5 %, and with high anticholinergic burden hyoscine butylbromide and amitryptiline in 13.1 %. Discussion: The medical attention of diseases of the elderly is complex and requires the prescription of multiple medications. It is important to evaluate the medicines and verify their relevance and possible pharmacological interactions, to avoid the presence of adverse events. For this reason, scales have been developed, they allow improving therapeutic results, and especially in medicines with anticholinergic burden and systems of clinical alerts that promotes correct formulation.